Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 304

1.

B7-H6-mediated down-regulation of NKp30 in natural killer cells contributes to HIV-2 immune escape.

Lucar O, Sadjo Diallo M, Bayard C, Samri A, Tarantino N, Debré P, Thiébaut R, Brun-Vézinet F, Matheron S, Cheynier R, Vieillard V; ANRS CO5 IMMUNOVIR-2 Study group.

AIDS. 2018 Oct 15. doi: 10.1097/QAD.0000000000002061. [Epub ahead of print]

PMID:
30325780
2.

Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients.

Colin de Verdiere N, Durier C, Samri A, Meiffredy V, Launay O, Matheron S, Mercier-Delarue S, Even S, Aboulker JP, Molina JM, Autran B, Simon F; and the ANRS EP46 NOVAA Group.

AIDS. 2018 Oct 23;32(16):2291-2299. doi: 10.1097/QAD.0000000000001963.

PMID:
30096071
3.

T-Cell Receptor Excision Circles in HIV-Exposed, Uninfected Newborns Measured During a National Newborn Screening Program for Severe Combined Immunodeficiency.

Warszawski J, Thomas C, Dialla O, Garrait V, Dollfus C, Reliquet V, Clech L, Dert C, Mandelbrot L, Audrain M, Blanche S; ANRS EPF Study Group.

J Pediatr. 2018 Jul 3. pii: S0022-3476(18)30777-7. doi: 10.1016/j.jpeds.2018.06.008. [Epub ahead of print]

PMID:
29980289
4.

First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2).

Matheron S, Descamps D, Gallien S, Besseghir A, Sellier P, Blum L, Mortier E, Charpentier C, Tubiana R, Damond F, Peytavin G, Ponscarme D, Collin F, Brun-Vezinet F, Chene G; France REcherche Nord&Sud Sida-Hiv Hépatites (ANRS) 159 HIV-2 Trial Study Group .

Clin Infect Dis. 2018 Sep 28;67(8):1161-1167. doi: 10.1093/cid/ciy245.

5.

Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads.

Le Hingrat Q, Perrier M, Collin G, Drumard S, Storto A, Bertine M, Larrouy L, Matheron S, Damond F, Charpentier C, Descamps D, Visseaux B.

J Virol Methods. 2018 Jul;257:12-15. doi: 10.1016/j.jviromet.2018.03.010. Epub 2018 Mar 26.

PMID:
29588254
6.

Assessement of Awareness of, Concerns and Attitudes Towards HIV-Related Court-Case Sentences in France in a Representative Sample of People Living with HIV (ANRS VESPA2 Survey).

Suzan-Monti M, Celse M, Vilotitch A, Demoulin B, Dray-Spira R, Yéni P, Lert F, Spire B; ANRS VESPA2 study group.

AIDS Behav. 2018 Oct;22(10):3264-3272. doi: 10.1007/s10461-018-2077-6.

PMID:
29512033
7.

Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients.

Storto A, Visseaux B, Bertine M, Le Hingrat Q, Collin G, Damond F, Khuong MA, Blum L, Tubiana R, Karmochkine M, Cazanave C, Matheron S, Descamps D, Charpentier C; ANRS HIV-2 CO5 Cohort.

J Antimicrob Chemother. 2018 May 1;73(5):1173-1176. doi: 10.1093/jac/dkx530.

PMID:
29415189
8.

Corrigendum to "HIV-2 molecular epidemiology" [Infect. Genet. Evol. 46 (2016) 233-240].

Visseaux B, Damond F, Matheron S, Descamps D, Charpentier C.

Infect Genet Evol. 2018 Mar;58:294. doi: 10.1016/j.meegid.2017.12.024. Epub 2018 Jan 5. No abstract available.

PMID:
29307762
9.

HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.

Benhammou V, Tubiana R, Matheron S, Sellier P, Mandelbrot L, Chenadec JL, Marel E, Khoshnood B, Warszawski J; ANRS CO1/CO11-EPF French Perinatal Cohort study group.

J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):439-450. doi: 10.1097/QAI.0000000000001618.

PMID:
29287028
10.

Correction to: Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.

Bruneel F, Tubach F, Mira JP, Houze S, Gibot S, Huisse MG, Megarbane B, Choquet C, Corne P, Peytel E, Villers D, Camus C, Bouchaud O, Caumes E, Girard PM, Simon F, Kalloumeh A, Roy C, Durand R, Le Bras J, Matheron S, Wolff M; PALUREA Study Group.

Intensive Care Med. 2018 Jan;44(1):141-143. doi: 10.1007/s00134-017-4978-7.

PMID:
29138897
11.

CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study.

Wittkop L, Arsandaux J, Trevino A, Schim van der Loeff M, Anderson J, van Sighem A, Böni J, Brun-Vezinet F, Soriano V, Boufassa F, Brockmeyer N, Calmy A, Dabis F, Jarrin I, Dorrucci M, Duque V, Fätkenheuer G, Zangerle R, Ferrer E, Porter K, Judd A, Sipsas NV, Lambotte O, Shepherd L, Leport C, Morrison C, Mussini C, Obel N, Ruelle J, Schwarze-Zander C, Sonnerborg A, Teira R, Torti C, Valadas E, Colin C, Friis-Møller N, Costagliola D, Thiebaut R, Chene G, Matheron S; COHERE in EuroCoord and ACHIeV2e Study Group.

J Antimicrob Chemother. 2017 Oct 1;72(10):2869-2878. doi: 10.1093/jac/dkx210.

PMID:
29091198
12.

Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.

Tron L, Lert F, Spire B, Dray-Spira R; Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 Study Group.

HIV Med. 2017 Mar;18(3):181-195. doi: 10.1111/hiv.12412. Epub 2016 Jul 6.

PMID:
28967199
13.

No evidence for major adverse events related to suspicion of Ebola in France, 2014-2015.

Lachâtre M, Méchain M, Etienne M, Gautret P, Matheron S, Nahon M, Coignard-Biehler H, Malvy D, Duval X, Tattevin P.

Clin Microbiol Infect. 2018 Mar;24(3):310-311. doi: 10.1016/j.cmi.2017.09.004. Epub 2017 Sep 9. No abstract available.

PMID:
28899839
14.

Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.

HIV Med. 2018 Jan;19(1):42-48. doi: 10.1111/hiv.12536. Epub 2017 Jul 25.

PMID:
28741837
15.

New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification.

Bertine M, Gueudin M, Mélard A, Damond F, Descamps D, Matheron S, Collin F, Rouzioux C, Plantier JC, Avettand-Fenoel V.

J Clin Microbiol. 2017 Sep;55(9):2850-2857. doi: 10.1128/JCM.00755-17. Epub 2017 Jul 12.

16.

Zika virus infection: report of the first imported cases in a Paris travel centre.

Sokal A, D'Ortenzio E, Houhou-Fidouh N, Brichler S, Dorchies J, Cabras O, Leparc-Goffart I, Yazdanpanah Y, Matheron S.

J Travel Med. 2016 Jul 1;24(1). doi: 10.1093/jtm/taw066.

PMID:
28679155
17.

Cyclophilins and nucleoporins are required for infection mediated by capsids from circulating HIV-2 primary isolates.

Mamede JI, Damond F, Bernardo A, Matheron S, Descamps D, Battini JL, Sitbon M, Courgnaud V.

Sci Rep. 2017 Mar 27;7:45214. doi: 10.1038/srep45214.

18.

Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort.

Perrier M, Charpentier C, Peytavin G, Lê M, Blondel L, Visseaux B, Joly V, Pinto A, Matheron S, Yazdanpanah Y, Descamps D, Landman R.

J Antimicrob Chemother. 2017 Jun 1;72(6):1745-1751. doi: 10.1093/jac/dkx018.

PMID:
28186251
19.

Preferential expression of domain cassettes 4, 8 and 13 of Plasmodium falciparum erythrocyte membrane protein 1 in severe malaria imported in France.

Argy N, Bertin GI, Milet J, Hubert V, Clain J, Cojean S, Houzé P, Tuikue-Ndam N, Kendjo E, Deloron P, Houzé S; CNRP Study Group.

Clin Microbiol Infect. 2017 Mar;23(3):211.e1-211.e4. doi: 10.1016/j.cmi.2016.10.012. Epub 2016 Oct 20.

20.

Prevalence of and factors associated with depression among people living with HIV in France.

Feuillet P, Lert F, Tron L, Aubriere C, Spire B, Dray-Spira R; Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)-VIH: Enquête sur les personnes atteintes (Vespa2) Study Group.

HIV Med. 2017 Jul;18(6):383-394. doi: 10.1111/hiv.12438. Epub 2016 Sep 14.

PMID:
27625202

Supplemental Content

Loading ...
Support Center